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Executive Summary 
 
 There is no overall health policy at EU level but internal market legislation is increasingly influencing 
national level health policies and systems especially in relation to cross-border healthcare 
 The current review of internal market by EC is expected to be followed by a Communication on 
Services of General Interest (late 2007) 
 Global service companies have expanded into countries of Central and Eastern Europe 
 Multinational healthcare companies increasingly involved in direct provision of healthcare services to 
the public sector and public – private partnerships 
 Several healthcare companies have been bought by private equity funds, e.g. Capio, Gambro 
healthcare   
 
 
 
This paper reviews multinational companies involved in the healthcare sector, focusing on companies that 
either have, or are eligible for a European Works Council (EWCs).  The paper starts with an outline of 
European Works Councils in EU legislation, followed by public health and healthcare policy in Europe.  This 
is followed by an overview of issues facing multinational companies involved in the healthcare sector.  A 
series of short company profiles follows which includes a) companies eligible for EWCs, b) companies not 
yet eligible for EWCs but which show signs of expansion outside their immediate domestic market.  
1 European Works Councils and EU legislation  
 
The European Works Councils (EWC) Directive, initially adopted in 1994
1
, aims to improve the right of 
workers to information and consultation in trans-national companies. It requires transnational companies to 
establish information and consultation agreements covering their entire European workforce, if they have not 
already done so. The content of these agreements is largely left to negotiation between management and 
employee representatives, but minimum requirements where management refuses to negotiate include the 
requirement of annual reports to the EWC on the company‟s business prospects, and the right to be 
informed about exceptional circumstances affecting employees‟ interests, such as closure or collective 
redundancy.  
 
The EWC directive applies to companies, 
2
 or groups of companies
3
, with  
 
 at least 1000
4
  employees across the member states, 
5
 and 
 at least 150 employees in each of two or more distinct member states. 
 
These employment criteria represent a lower bound – companies meeting them are obliged to establish a 
EWC, but companies which do not meet them may nonetheless choose to establish one voluntarily. In a 
number of instances companies have chosen to do so, whether it be for purposes of labour relations, 
prestige in order to demonstrate Europe-wide coverage, or, in the case of UK during its opt out,  in the 
expectation of the future introduction of a legal obligation. 
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2 Health policy in Europe 
2.1 Historical background  
 
Since the creation of the Common Market (1987/1989) health competences have been promoted to foster a 
common market. Other aspects of health policy have evolved as a result of policy developments in related 
fields.  Health policy has traditionally been caught between the EU Treaties implemented through European 
legislation and the European Court of Justice (ECJ), and policy making which has been consensual between 
member states.  Recently, the ECJ has had an influence on health policy in the fields of health care, 
medicines, environment, workplace health and safety and pharmaceuticals/ distribution.  Health care has 
been most strongly influenced by the concept of subsidiarity with national governments considering national 
health care systems to be their own responsibility.   
 
The Single European Act of 1986 established an extension of the Community actions in relation to health 
although health policy was not treated as a separate policy area.  It did extend the scope of occupational 
health and safety, and environmental and consumer protection.
6
  
 
The Treaty of European Union (Maastricht Treaty) of 1992 amended the Treaty of Rome with a formalisation 
of the powers relating to health care. Article 3(o)  “contributes to the attainments of a high level of health 
protection”. Article 129 dealt with public health and the prevention of disease and provided a framework for 
working towards health protection.   Article 3(b) established the principle of subsidiarity especially in relation 
to health care, which has effectively limited the Community‟s role in health.  
   
The Treaty of Amsterdam resulting from the Intergovernmental Conference of 1997 and finally ratified in 
1999 has a specific Article 152 relating to public health. 
7
  It states  
“Community action, which shall complement national policies, shall be directed towards improving 
public health, preventing human illness and diseases, and obviating scourges of danger to human 
health”.   
It also states  
“Community action in the field of public health shall fully respect the responsibilities of the Member 
States for the organisation and delivery of health services and medical care”.   
There was also a reassertion of the subsidiarity principle in relation to health care systems. 
 
As a result of agreeing Article 152, a new Directorate was set up for Health and Consumer Affairs, which 
drafts proposals for legislation.  The European Parliament deals with health issues through the Committee 
for Environment, Public Health and Consumer Protection.  Health policy actually cuts across all directives 
and there is no coherent health strategy. 
 
2.2 Constitutional Treaty on public health 
 
The former Constitutional Treaty introduced two significant elements on public health.  The “well being” of 
people living in Europe became an aim of the EU (article I-3: the Union‟s objectives).   Access to preventive 
health care and treatment was recognised as fundamentally right (article II-95).
8
  The EU was also given a 
stronger mandate to fight health threats, including tobacco and alcohol and to promote cooperation between 
member states.  However, at the Inter-governmental Council in July 2007 this was reduced to “incentive 
measures” because of an attempt to block the possibility that the EU harmonising legislative and regulatory 
provisions for member states.
9
  Focusing on public health threats but not having the power to influence cross 
European policies, for example on alcohol, shows the limits to these new health competences. The 
emphasis on health prevention can also be used to promote individual liability for health care costs. 
10
  
 
Within the Treaty, a Fundamental Charter of Human Rights was incorporated, which would have been legally 
binding after ratification.  However, at the 2007 June Summit, the UK, Poland and Ireland were attempting to 
“opt-out”of the Charter.
11
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2.3 Healthcare and competition policy 
 
Subsidiarity has been an important principle that has enabled national health services in Europe to 
determine their own policies but the impact of several EU Directives, for example, the movement of 
professionals, is beginning to influence national health systems directly.  One of the major issues facing 
national healthcare systems is whether healthcare institutions are subject to competition law.  The key 
question is whether they engage in economic activity.  Each activity has to be judged on its merits.  
However, the results of health care reforms often mean that with the introduction of market mechanisms and 
decentralisation, healthcare institutions are more likely to be considered subject to competition law.  This 
makes them less obviously defined as ”services of general interest”. 
 
Several rulings by the European Court of Justice (ECJ) have ruled in favour of increasing the choices 
available to the patient or healthcare consumer, by accessing healthcare in another EU country.  This has 
made national governments more aware of the implications of greater consumer choice in healthcare, 
policies, which many governments, themselves, are promoting.  The combination of an increasing demand 
for healthcare services, with increased choice, will result in more patients being treated in countries, which 
are not the patient‟s main place of residence.  The ECJ has ruled in favour of patients who move to other 
member states without having prior approval for non-hospital treatments, then pay for treatment received 
and can claim a refund from their home institutions.  “In cases where the patient did receive prior 
authorisation, it: 
 Should be delivered following a transparent and timely procedure, subject to judicial or semi-judicial 
control;  
 Should not results in patients receiving less money from what they would have received if they had 
stayed in state of origin;  
 Could not be refused treatment on purely national criteria;  
 Should be given if home member sate is unable to provide treatment in reasonable time. 
This last point refers to the Watts case, in the UK, where a long waiting list, was presented as the reason for 
pursuing cross-border treatment. 
12
 
2.4 Internal market for services 
 
In January 2004, the European Commission presented a proposed Directive on services in the internal 
market, which aimed to provide a legal framework to eliminate obstacles for the establishment of service 
providers and barriers to the free movement of services.
13
  This had several implications for the healthcare 
sector.  Positively, it is expected to improve access to outpatient care because of simplifying the process of 
reimbursement of healthcare delivered to a patient in another Member state although some measures will 
have to be taken to avoid disparities between healthcare systems in certain countries.  
 
The final version of the Services Directive, approved by the European Parliament, excluded health and social 
care services. This was considered a major achievement for those campaigning against the Services 
Directive.  However, there are signs that any future Communication on either health or social care services 
will be influenced by the principles of competition and the operation of the internal market.   
 
In September 2006, the Commission issued a consultation paper on community action on health services.  It 
states that community action on health services should be based on two elements: 
 Legal certainty – to apply the legal findings of the ECJ rulings in relation to Treaty provision in 
relation to free movement of patients, professionals and health services i.e. cross border care  
 Support for member states – where European action can add value to national action for health 
services
14
 
 
The results of consultation showed that respondents felt that: 
• There was a lack of up to date information on cross border care 
• Patients needed more information 
• Responsibility for clinical oversight had to be in the country of treatment 
• There was concern about the potential for undermining national health care systems 
• Any European Commission proposal, on health services, should respect common values and 
principles in EU health systems 
• Continued respect for the subsidiarity principle was important 
• There were mixed views about need for “supportive tools” or legally binding measures 
15
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On 5
th 
 September 2006, the EU Health Commissioner, Markos Kyprianou, was reported as saying that the 
European Commission is willing to take an extreme position on the influence of the internal market in 
healthcare, ahead of any democratic debate on the issue. The EU Health Commissioner said "the internal 
market applies to health services. People can shop around. Opening the market could provide lucrative 
opportunities for private providers to lure clients".
16
  
 
A slightly less extreme version of this approach can be seen in the statement of Marcel Haag, Secretariat 
General, European Commission, in April 2007.  On 19 April 2007, Marcel Haag, at a conference on Services 
of General Interest, organised by the Committee of the Regions (CoR) and European Economic and Social 
Committee (EESC), reported that a review of the Internal Market was taking place.
17
  This will emphasise the 
benefits of the internal market for the citizen, bringing in the consumer and social dimensions.  Services of 
General Interest (SGI) have an essential role to play in this process, hence the proposed Communication on 
SGIs will be published after the internal market review is completed, which will probably be later in 2007.  
This is one of the most recent, publicly presented, views coming from the European Commission, which 
show how the logic of the internal market is still the driving force behind any formalisation of Services of 
General Interest. 
 
Groups within the European Parliament, for example, the Socialist Party of Europe, and the Council/ 
Committee of the Regions and the European Economic and Social Committee (EESC), support the 
campaign for a Services of General Interest (SGI) framework.  However, there is little evidence to show that 
a framework for SGIs will address the issues raised by the internal market and national health and social 
care policies.  The European Commission is pursuing its internal market policies, with only minimal 
commitment to establishing a framework of Services of General Interest.  
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3 Company overview 
 
The companies outlined in this paper see European and other global opportunities for expansion in different 
aspects of the healthcare sector: insurance, clinical and diagnostic services, and facilities management 
services.  Partnerships with the public sector are seen, by many companies, as an essential step towards 
developing and delivering new services and facilities.  The involvement of these companies in the delivery of 
services in the healthcare sector will have implications for health workers and for the accountability of public 
health systems.   
 
Since 2004, private equity funds have bought several healthcare companies. Private equity funds are 
created as partnerships by financial services companies, which invite investors, for example pension funds, 
to commit to the fund.  These funds are then used, either, to invest in companies, which are not quoted on a 
stock exchange, known as “private” companies, or in companies, which have shareholders and are quoted 
on a stock exchange “publicly listed company (plc)”.  Usually, once a publicly listed company is bought by a 
private equity fund it is de-listed from a stock exchange and becomes a “private”  company.
18
   
 
The immediate effect of no longer being publicly listed companies is that reporting requirements for these 
companies are much less rigorous.  There are fewer obligations to put information, about the company, into 
the public domain.  This can be seen in much more limited information being available on company websites, 
or fewer press releases published on acquisitions, mergers or company reorganisations.  This has 
fundamental implications for research into company strategies or market developments.  It also makes any 
form of accountability and transparency of healthcare services, provided by the private sector, to the public 
sector, more difficult to monitor. 
 
There are also other impacts on the companies that have been taken over by private equity funds.  There is 
a lack of reliable evidence of the actual impact on employment.  Hall (2007) argues that there is a need for 
more detailed research on the actual impact on employment, pay and industrial relations in each buyout in 
recent years as well as greater information rights for employees and investors.
19
  There are growing 
concerns that the activities of these private equity funds are not sustainable, often being supported by debt, 
and may result in bankruptcies.   The reports of high returns from private equity investments are also being 
questioned, with the results actually lower than comparable investments in shares.
20
 
 
Companies involved in the healthcare sector in Europe can be divided into two main groups: 
3.1 Global service companies 
 
Global services companies, such as Compass, ISS, Sodexho, Rentokil-Initial, and Aramark, deliver a range 
of support services for several sectors, including the healthcare sector.  They deliver services such as 
catering, cleaning, buildings management, portering, and reception. In the case of ISS and Rentokil, there is 
evidence of these larger companies buying small companies that had previously provided services to the 
healthcare and other sectors.  A process of consolidation has been taking place over the past decade. 
21
     
 
There have been changes in relation to the type of contracts that companies have taken on since the mid 
1990s.The level of risk that the contractor is expected to take on has increased.  This can be seen in the 
move from „cost-plus‟ contract, where the contractor charges a management fee and charges the costs to 
the client, to „total risk‟ contracts, where the contractor rents space from a client and provides and markets 
services on-site.
22
   
 
There is limited room for growth in catering expansion in the business and industry sector so that catering 
companies are looking for alternative markets. 
23
 Large caterers such as Compass and Sodexho have 
expanded into facilities management.  Contractors are also providing a range of other support services, such 
as housekeeping and maintenance, reception, security, laundry, bar and retail shops.  About 30% of recent 
Sodexho growth has been in non-food services. 
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Since the entry of several countries from Central and Eastern Europe into the European Union, several 
global service companies have expanded into the „new„EU member states.  Central and Eastern European 
countries are seen as emerging markets for catering, cleaning and facilities management industries. 
 
Aramark, Compass, ISS, Sodexho and Rentokil-Initial all have European Works Councils. These companies 
are active in the health care sectors to varying degrees.  ISS and Sodexho both have extensive activities in 
the healthcare sector.  
 
Three of these companies have de-listed since 2005.   Aramark was bought out by its CEO in 2007, with 
financial backing from several private equity funds. In 2005, ISS was bought out by PurusCo A/S, a 
consortium of EQT (a Swedish private equity company) and Goldmann Sachs Capital Partners.  Sodexho 
was de-listed from New York Stock exchange in July 2007. 
 
3.2 Healthcare companies that provide healthcare directly 
 
A relatively small, but growing, group of companies deliver healthcare, in more than one country, in Europe.  
Capio is a Swedish healthcare company that is expanding in Europe.   It focuses mainly on different ways of 
delivering acute care.  It has expanded into Spain and Germany since 2005 as well as expanding its 
operations in the UK.  In 2006, it was bought by Opica, a company “indirectly jointly owned by  
Apax Partners Worldwide LLP, by Nordic Capital Fund VI and by funds advised or managed by Apax 
Partners SA”.  The company was de-listed in November 2006.  It is currently selling its UK hospitals. 
 
BUPA has been both a health insurer and healthcare provider in the UK, for several decades, but sold its 25 
hospitals in June 2007.  In Spain, its subsidiary, Sanitas, has recently been awarded a public-private 
partnership to build and run a new hospital in Valencia.  Due to changes in legislation, BUPA has sold its 
health insurance activities in Ireland.  In the UK, it has expanded in the past decade into residential care for 
older people and this has been a major source of growth as well as nursery care.  Day nurseries are the 
fastest growing small business sector in the UK with for-profit providers starting to expand their share of the 
market.
24
  
 
Gambro and Fresenius are both renal care companies that started by manufacturing products and 
equipment for kidney dialysis but have expanded in the last decade into managing dialysis clinics. The global 
renal care industry is highly competitive. The Gambro healthcare division has been sold to Bridgepoint, a 
private equity company. Fresenius has consolidated its activities in hospital management. 
  
There are several issues facing healthcare companies:   
1. Companies view their relationships with government/ public healthcare sector as crucial to future 
company growth.  Some companies are building up their experience of working with the public 
sectors.   
 
2. There are several examples in Europe of governments contracting private companies to manage a 
public sector hospital.  In some countries this also involves the private company in building the 
hospital.  The Private Finance Initiative (PSI) in the UK has mainly involved global service 
companies.  Examples of hospitals where private healthcare companies have been contracted to run 
hospitals in the public sector are:  
 St.Goran‟s Hospital, Stockholm, Sweden – Capio  
 Ribera Hospital, Valencia, Spain – ADESLAS 
 Manises Hospital, Valencia – Sanitas (BUPA)  
 Omegna Hospital, Piedmont, Italy – Generale de Sante 
 Hospital Amadora, Sintra, Portugal - Jose de Mello Saude  
 
3. Expansion into Central and Eastern Europe by healthcare companies has been slow, although two 
companies, Medicover and Euromedic International, have continued to expand since 2004.  
Euromedic International is now expanding into Western Europe.   
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Companies will be considered in the following groups. 
 
Companies eligible for EWCs 
 
Alliance Medical Group 
Aramark 
BUPA 
Capio 
Carema 
Cinven 
Compass 
Euromedic International 
Fresenius 
Gambro 
ISS 
Medicover 
Rentokil 
Sodexho 
 
Non eligible Adeslas 
Genérale de Sante 
José de Mello Saude 
 
 
3.3 EWC eligible companies 
 
Company 
name 
(company’s 
major owner) 
Major presence in 
Europe (countries) 
Workers EWC (date 
introduced) 
  Worldwide Europe Other  
Alliance 
Medical 
Group 
UK, Italy, Netherlands, 
Poland  
   No 
Aramark UK, Czech Republic, 
Belgium, Spain, 
Germany, Ireland 
240,000 75,000 
(non-US) 
- Yes (1996) 
BUPA UK, Spain 9,120 9,120 - No 
Capio Sweden, Finland, 
Norway, Denmark, UK, 
France, Spain, 
Germany 
16,000 16,000 - Yes (2006) 
Carema  Sweden, Finland, 
Norway 
   No 
Cinven UK , Spain, Portugal  - 8,300 
employees 
and 5,300 
clinical staff 
– “under 
contract” 
Morocco?-  
Compass 
 
Austria,  Belgium, 
Croatia, Cyprus, Czech 
Republic, Denmark, 
Estonia, Finland, 
France, Germany, 
Greece, Hungary, 
Iceland, Italy, Kosovo, 
Latvia, Lithuania, 
379,018 
 
138,144 
(36%) 
N.America 
140,096 (37%) 
Rest of world 
100,778 (27%) 
Yes (1996) 
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Luxembourg, 
Netherlands, Norway, 
Poland, Portugal, 
Romania, Slovakia, 
Spain, Sweden, 
Switzerland, Spain,  
UK, Ireland 
Euromedic 
International 
Bosnia Herzogovina,  
Croatia, Czech 
Republic, Greece,  
Hungary, Ireland, 
Portugal, Poland,  
Romania, Russia, 
Turkey  
   No 
Fresenius Austria, Belgium. 
France, Germany, Italy, 
Sweden, UK,  Spain,   
107,438 52,644 
(49%) 
N.America 
39,752 (37%) 
L.America 
9,666 (9%) 
Asia-Pacific 
5,370 (5%) 
Yes (1996) 
Gambro 
Healthcare 
Estonia, France, 
Hungary, Italy, 
Lithuania, Poland, 
Portugal, Spain, 
Sweden, UK 
?   Yes (1999) 
ISS 
 
 
Denmark, UK, Sweden,  
Austria, Belgium, 
Croatia, Czech 
Republic, Denmark, 
Finland, France, 
Germany, Greece, 
Hungary, Iceland, 
Ireland, Italy, 
Luxembourg, 
Netherlands, Norway, 
Poland, Portugal, 
Romania, Slovakia, 
Slovenia, Spain, 
Sweden, UK  
391,000 285.945 
(73%) 
 105,455 
(27%) 
Yes (1995) 
Medicover 
 
Estonia, Czech 
Republic, Hungary, 
Poland, 
Romania 
1,587 1,587  No  
Rentokil 
 
 
 
Austria, Belgium, 
Czech Republic, 
Denmark, Finland, 
France, Germany, 
Greece, Italy, The 
Netherlands, Norway, 
Portugal, Ireland, 
Spain, Sweden, 
Switzerland, UK   
92,447   Yes (1996)  
Covers countries 
of EU, Norway 
and Switzerland 
Sodexho Austria, Belgium, 
Bulgaria, Czech 
Republic,  Denmark, 
France, Finland,  
Germany, Greece, 
Hungary, Iceland, 
Ireland, Italy, 
Luxembourg, 
Netherlands, Norway, 
Poland, Portugal, 
Romania, Russia, 
Serbia Montenegro,  
Slovakia, Slovenia, 
Spain, Sweden, 
Switzerland, and the 
324,000 136,080 
(42%) 
119,660 North 
America States 
(37%)  
 68,040 Rest of 
world (21%)  
Sodexho Partena 
– Yes (1998) 
 
Sodexho Pass/ 
Sodexho 
Universal - No  
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UK.    
 
Source: Company Annual Reports; European Works Councils Agreements database www.ewcdb.eu 
(accessed July 2007) 
 
3.4 Non-EWC eligible companies 
 
Company 
Name 
Major presence 
in Europe 
Workers 
  Worldwide Europe Other 
Adeslas Spain  - Spain   
Generale de 
Sante 
France, Italy  - France, 
Italy  
 
Jose de Mello 
Saude 
Portugal 
Spain 
- Portugal 
Spain 
Brazil 
 
3.5 Significant acquisitions and sales of subsidiaries since 2004 
 
Company Buying Selling Comment 
Alliance Medical 
Group 
- - - 
BUPA 
 
 
 
 
2005 - ANS Care 
Homes 
2006 - Clinovia – 
home health care 
2007 –Euro-
residencias Care 
Homes 
(Sanitas/Spain) 
 
2007 – 25 UK 
Hospitals to Cinven 
Sales of hospitals in UK to finance debt 
from sale of BUPA Ireland and long-
term international expansion 
Acquisition of Euroresidencias Care 
Home and Day centres makes Sanitas 
the second largest care home provider 
in Spain 
Capio 
 
 
 
2005 - Grupo 
Sanitario IDC (Spain) 
2006 - Arvita Hospital 
Group (France) 
2006 - Clinique La 
Rochelle and Clinique 
Saint Jean 
Languedoc (France) 
2006 - Deutsche 
Klinik (Germany) 
2006 - Tonkin Group 
(France) 
2005 - Clinique 
Saint Vincent 
France 
2005 - La Metairie 
clinic (Switzerland) 
2005 - closes Dreux 
clinic (France) 
2007 UK Capio sold 
to Ramsay Health 
Care Limited 
(mental health 
services & 
laboratory services 
remain with Capio) 
Capio has achieved its goals of moving 
into Spain and Germany as well as 
consolidating its presence in France 
and the UK. 
It has also negotiated longer contracts – 
St. Gorens, Sweden  and Spain 
Valdemoro, (30 years) Spain 
Cinven 
 
2005 - Partnerships 
in Care (mental 
health services) from 
General Health Care 
Group (UK) 
2007 - 25 BUPA 
hospitals 
2007 - USP 
Hospitales Group 
from Mercapital 
(Spain) 
 Signs of a consolidated expansion into 
healthcare  in UK and Spain 
Fresenius 2005 - HELIOS Klinken   
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Group 
2005 Renal Care 
Company (US) 
2006 - HUMAINE 
Klinken  
 
 
 
Gambro 
healthcare 
2006 - 11 dialysis clinics 
Lithuania 
2005 - Sold all US 
clinics to Da Vita 
 
Divested all US clinics to Da Vita 
 
 
 
Generale de 
Sante 
2006 - Hexagone Group 
Clinics in Italy: Casa 
Di Cura San Secondo 
De Asti,  
Poggio Del Sole, 
Villa Maria Teresa, 
Il Pergolino 
Property assets 
sold to Sofco 
(Gecina group) 
Consolidation of Italian expansion 
Adeslas 
 
2006 - La Policlínica 
San José, Vitoria 
90% of Clínica Santa 
Catalina Las Palmas 
de Gran Canaria, 
Santa Cruz de 
Tenerife 
 No recent expansion into either Europe or 
Latin America 
Jose de Mello 
Saude 
 
2006 - 35% of Quiron 
private hospital 
group, Spain 
 First expansion into Spain 
 
3.6 Global reach of companies 
 
Parent 
company 
Sales (2006) Healthcare division Sales % 
Aramark $10 billion n/a - - 
Compass £10.815m Healthcare £1,730 16% 
Fresenius €10,777m Fresenius Medical Care 
Fresenius Proserve 
€8,499 
 
€2,155 
78% 
 
20% 
Gambro  Healthcare   
Rentokil 
Initial 
£2,124m n/a   
ISS DKK 55,772m n/a   
Sodexho €12,798m Healthcare €2,839m 25% 
 
3.7 Recent company involvement in PPPs since 2005 
 
Company Country Projects Date 
Fresenius Austria 
Bosnia 
Radiation centre, Upper Austria (VAMED) 
Other PPP projects in development in 
Central Europe 
 
Capio 
 
Sweden Valdemoro, Madrid, Spain 2006 
BUPA/ 
Sanitas 
Spain Manises Hospital, Valencia, Spain 
 
2007 
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4 Companies with EWCS or EWC eligible 
 
4.1 Company ALLIANCE MEDICAL  
 
Owner: Bridgepoint, a private equity company 
 
Address: 
Alliance Medical Limited 
Iceni Centre 
Warwick Technology Park 
Warwick CV34 6DA 
 
Tel: +44 (0)1926 482000 
Fax: +44 (0)1926 482020 
email: info@alliance.co.uk 
 
http://www.alliancemedical.eu.com/ 
 
EWC: Eligible? 
 
Total employees:  400 staff in UK plus ??
25
 
 
Regional distribution 
 
European subsidiaries 
 
Company Country 
Alliance Medical UK 
Alliance Medical Italy  
Alliance Viamed (joint venture) Spain 
Alliance Medical Poland 
Alliance Medical Interim Solutions UK – European business 
development 
 
Alliance Medical Group provides PET, MRI, CT, and mammography services.  It provides extensive, 
outsourced mobile services as well as fixed site services.   
 
Alliance Medical was formed in 1989 by Robert Waley-Cohen, who had previously co-founded Alliance 
Imaging Inc. in the USA in 1983. The company started to operate in the UK in 1990.  In 1996,  a 
management buyout was backed by 3i plc and Foreign & Colonial.  In 1998, Alliance Medical started sending 
mobile scanners to Italy and formed a joint venture with ETF in 1999, Italy‟s only supplier of mobile 
diagnostic services. 
 
Bridgepoint bought out 3i and Foreign and Colonial in 2000.  A new division, Interim Solutions, was set up to 
rent out equipment across Europe.  In 2002, Alliance Medical acquired 100% of  Alliance Diagnostic, an 
Italian company, and formed a joint venture company in Spain,  There is no more recent history of the 
company provided on its website after 2003, however, it has continued to win contracts from the NHS.  The 
company runs two Intermediate Treatment Centres in the UK with the Partnership Health Group in SW 
England and provides equipment for at least 19 hospitals with hospitals in the UK.     
 
There has been some criticism of the quality of services delivered by Alliance Medical in the UK, including 
mistakes in the interpretation of images and delays in the delivery of results.  Doctors in Belgium, South 
Africa and Spain interpret the data and do not collaborate with doctors in the NHS.
26
  There have also been 
questions asked in Parliament about the contacts between Alliance Medical and the Department of Health in 
the period before one contract was awarded in 2004.   
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In January 2007, Alliance Medical, in partnership with Care UK, was awarded preferred bidder status to 
provide diagnostic services across the North East of England.  The service will be delivered under a joint 
brand name of AMC Diagnostics Limited.  The service will offer CT scans, MRI scans, DXA (bone 
densitometry), electrocardiograms, ultrasound/echo and X-ray, upper and lower gastrointestinal endoscopy, 
electroencephalography, electromyography/nerve conduction studies, flexible cystoscopy.
27
  
 
4.2 Company name  ARAMARK 
 
Owners: 
After being re-listed in the stock market in 2001, an investor group, led by Joseph Neubauer (CEO) and 
investment funds managed by GS Capital Partners, CCMP Capital Advisors and J.P. Morgan Partners, 
Thomas H. Lee Partners and Warburg Pincus LLC, bought all Aramark shares.  The company was de-listed 
26 January 2007.   
 
Address: 
ARAMARK 
1101 Market Street 
Philadelphia 
Pa 19107   USA 
www.aramark.com 
 
EWC: YES 
 
Total employees: 240,000  (160,000 full-time and 80,000 part-time) 
 
Regional breakdown 
 
Activities Sales Employees 
United States 64% 150,000 
 
International food and support services 22% 75,000 
Uniform services 14% 14,800 
 
Source: Aramark 10-K 2006 
4.2.1 Major European subsidiaries   
 
Company Ownership Country Website 
ARA Services 
Ltd 
Campbell 
Catering Ltd 
100% UK www.aramark.com 
Aramark 
Cleaning SA 
Aramark SA  
100% Belgium www.aramark.com 
Aramark Gmbh 100% Germany www.aramark.com 
Aramark Ireland 
Holdings Ltd 
100% Ireland www.aramark.com 
Aramark SRO 100% Czech 
Republic  
www.aramark.com 
Aramark Slovak 
Republic SRO 
100% Slovak 
Republic 
www.aramark.com 
 Aramark 
Szolgaltato Es 
Kereskedelmi 
KFT 
100% Hungary www.aramark.com 
 
4.2.2 Company activities and strategy 
Aramark is a global company providing food, support and uniform services.   Since 2004, it has expanded 
into several countries in Central and Eastern Europe. In 2005, the Kent Institute of Medicine and Social care 
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was considering getting the Salvation Army and Aramark to fund joint research staff and developing a 
laboratory based consultancy service.
28
   
4.3 Company name BUPA 
 
Owner:  
BUPA  
BUPA House 
Bloomsbury Way 
London WC1A 2BA 
www.bupa.com 
  
EWC: NO – ELIGIBLE 
 
Total employees:  9,120 (Europe) 
 
Regional breakdown (Europe) 
 
Country Number of  employees 
UK 6,950 
Spain 2,000 
Total 9.120 
 
4.3.1 Major European subsidiaries 
 
Company Ownership Country Contact Website Employees 
Sanitas – 
Spain 
100% Spain c/via Augusta 13-15, 
28042 Madrid 
Tel: + 902 10 24 00 
www.sanitas.es 
 
2,000 
BUPA UK 
Insurance 
100% UK BUPA House 
Bloomsbury Way 
London WC1A 2BA 
 
www.bupa.com 6,950 
BUPA Care 
Services Ltd 
100% UK  www.bupa.com 
BUPA 
Childcare 
Services Ltd 
100% UK  www.bupa.com 
Strand 
Nurses 
Bureau Ltd 
100% UK  www.bupa.com 
 
4.3.2 Company outline and strategy 
 
BUPA is one of the two largest providers of private health insurance in the UK with 40.1% of the market.   
 
In the last 10 years BUPA has expanded through a series of acquisitions in the UK and worldwide.  Its most 
striking area of expansion has been into care services.  BUPA Care Services consist of the three 
subsidiaries: BUPA Nursing Homes ltd, BUPA Care Services Ltd and Care First Group plc.   BUPA runs 223 
care homes, 54 sheltered retired homes and in 1999 cared for 26,000 people in residential care or through 
home care services.  BUPA has also expanded into nursing and other care services. 
 
In September 2005, BUPA Care Homes acquired ANS plc, the 7th largest care home operator in the UK for 
£328m.   This will make BUPA the leading care home operator in the UK, with 21,000 beds and 297 homes 
with a turnover of £535m.
29
  In January 2006, BUPA bought Clinovia, a UK home healthcare specialist for 
£87.7 million from Lyceum Capital. This will provide new opportunities for BUPA in the expanding out of 
hospital care market. 
30
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In 2007, BUPA sold its 25 hospitals to Cinven for £1.44 billion, in order to pay off debt and to focus on long 
term development of the company, internationally and in the care sector.  This is a dramatic change for 
BUPA, which has been one of the leading private sector healthcare providers in the UK.  BUPA also 
operates in Spain, Middle East, Thailand, Hong Kong, Singapore and Malaysia.   
 
BUPA Ireland was established in June 1996 but was sold to the Quinn Group in March 2007.  This was due 
to the imposition of the Risk Equalisation Scheme (RES), which would have involved selling double the 
anticipated surplus to the State owned insurer VHI.  
31
 
 
Sanitas is a Spanish health insurer and healthcare provider and was incorporated into BUPA in 1989.  In 
September 2006, Sanitas, won a government tender to build and run a large new public hospital in Manises, 
Valencia.  The 15 year PFI contract for the Valencia government involves building and managing the new 
hospital as well as updating and running primary care centres in the region, building a new health centre in 
Turis and renovating a specialist centre in Aldaya.  Sanitas has formed a consortium with Ribera Salud, 
(Sanitas 60%: Ribera Salud 40%),
32
 which is owned by Bancaja and Caja Mediterraneo, two Spanish banks.  
The project is worth €137 million.   The Horta Manises hospital will employ 700 staff and treat 140,000 
people in the province. Sanitas has two other hospitals, both in Madrid.
33
 
 
In 2007, the Sanitas group acquired Sanitas Residencial, BUPA Group‟s Spanish care home provider, has 
bought the Euroresidencias‟ care home and day centre portfolio from the Spanish company Saarema 
Inversiones.  This will make Sanitas, the second largest provider of long term care in Spain. 
 
4.4 Company name CAPIO 
 
Owners: In September 2006, Capio was bought by Opica, a company “indirectly jointly owned by  
Apax Partners Worldwide LLP, by Nordic Capital Fund VI and by funds advised or managed by Apax 
Partners SA.  The company was de-listed in November 2006. Opica AB is jointly owned by Apax Europe VI 
at 45 per cent, Nordic Capital Fund VI at 44 per cent and Apax France at 11 per cent.  
 
Address:  
Capio AB 
Gullbergs Strandgata 9  
P.O. Box 1064  
SE-405 22 Göteborg, Sweden  
Tel: +46 31 732 40 00  
Fax: +46 31 732 40 99  
www.capio.com 
 
EWC: YES 
 
Total employees: 16,000 ?? 
 
Company divisional breakdown 
 
Company name Number of employees 
Capio Nordic Norway 170 Sweden 2,100 
Capio UK ?? 
Capio Germany ?? 
Capio Spain 4,300 
Capio France 5,600 and 1,250 doctors 
Capio Diagnostics 1,000 
Total 16,000 
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4.4.1 Major European subsidiaries 
 
Company Ownership Country Website 
Capio Nordic 100% Sweden www.capio.se 
 
Capio UK 100% UK www.capio.co.uk 
 
Capio France 100% France www.capio.fr 
 
Capio Sanidad 100% Spain www.capio.es 
 
Capio 
Germany 
100% Germany www.capio.de 
 
 
4.4.2 Company activities and strategy 
Capio is a Swedish healthcare company, which is aiming to become a trans-European healthcare company.  
Since 2003, Capio has continued its expansion into France, Spain and Germany, as well as consolidating its 
provision of services to the public sector in Sweden, Norway, Denmark, Finland, Spain and the UK. 
 
One of the most significant developments since 2004, was the sale, in September 2006, of Capio to Opica, a 
company “indirectly jointly owned by Apax Partners Worldwide LLP, by Nordic Capital Fund VI and by funds 
advised or managed by Apax Partners SA”.  The company was delisted in November 2006 
 
In 2005, Capio acquired the Grupo Sanitario IDC (Spain), its first entry into the Spanish healthcare market.   
It also sold the Clinique Saint Vincent (France) and closed the Dreux clinic in France.  The same year, it also 
sold La Metairie clinic in Switzerland.   
 
In 2006, Capio made expanded significantly into the French healthcare market, by buying the Arvita Hospital 
Group, Clinique La Rochelle and Clinique Saint Jean Languedoc, and the Tonkin Group.  It also achieved 
one of its goals to enter the German healthcare market, by acquiring the Deutsche Klinik. 
 
Since 2004, Capio has achieved its goals of moving into Spain and Germany as well as consolidating its 
presence in France and the UK.  It has also negotiated longer contracts – St. Gorens, Sweden  and 
Valdemoro, (30 years) Spain.  The contract for Valdemoro, Madrid, is a contract on a capitation basis, which 
provides an annual fixed payment per head of population.  The contract involves building a hospital, which is 
expected to open at the end of 2007
34
. 
 
In January 2007, Capio Diagnostics was merged into Capio UK.  There are two hospital laboratories in the 
UK, which will be transferred to Capio UK. The aim is to build decentralised pathology services, outside the 
Capio health care business, especially at ‟point of care‟ testing 
35
 
 
Capio completed negotiations for its first European Works Council in July 2006. 
In May 2007, a property consortium, including property entrepreneurs Nick Leslau and Sir Tom Hunter 
agreed to buy the property portfolio of 21 private hospitals from Capio, worth £686m.  They will be leased 
back to Capio.  
36
 
In June 2007, Opica was given permission by the European Commission to sell Capio UK.
37
    This follows 
an earlier announcement that Capio UK was to become independent. 
38
   Opica bought Capio on condition 
that it sold the UK hospitals, “to avoid regulatory problems”.
39
  In September 2007, Capio sold its English 
acute hospitals to Ramsay Health Care Limited, an Australian company, which operates 65 hospitals in 
Australia and three in Indonesia.
40
  The mental health and laboratory services will remain with Capio.   
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4.5 Company name CAREMA 
 
Owner: H-Careholding AB which is made up of: 75.01% 3i Group plc and funds 15.94% Government of 
Singapore Investment Corporation (GIC) 5.12% Mehiläinen management, H-Careholding's Finnish 
subsidiary, via companies 3.47% Peter Weiderman, Chairman of Carema and H-Careholding 0.46% Bengt 
Marcusson, Director Business Area Care    
 
Kungsgaten 70 3tr 
SE 111 22 Stockholm 
Tel: +46 8 617 3900 
Fax: +46 8 617 3980 
www.carema.se 
 
Total number of employees 4,500  
 
Company outline and strategy 
Carema is a Swedish company founded in 1996 and provides specialist care, primary care, care of older 
people, psychiatry, care of people with disabilities, and staffing.  The company specialised in integrated care. 
It is active in Norway, Sweden and Finland. 
 
There are three business areas in the Healthcare Business Unit 
 Primary care runs 20 healthcare centres in Sweden 
 Specialist care runs specialist healthcare in local hospitals, elective surgery and rehabilitation under 
the name of Carema Specialist Healthcare.   
 Recruitment which runs the Rent a Doctor, rent a nurse, and care team brands. 
All business units work on behalf of local councils.  Councils pay for 100% of primary care services. Councils 
account for 90% of the recruitment business unit‟s revenue with the rest coming from private companies.  It 
also has a very limited income from private health insurance and people who fund their own treatment. 
 
The Nursing Business Unit provides support, services and care to people with physical and psychological 
problems (Care and Psychiatry).  Also part of the Nursing Business Unit is elderly care.  It is the biggest 
player in Sweden and provides care to 4,500 people in 40 centres.  The company operates under contract, 
under its own management and other customer systems.  The business unit is paid for its services by 
municipalities.  This represents 70% of its turnover.  The Nursing Business Unit is active in Norway, Sweden 
and Finland. 
 
4.6  Company Name CINVEN 
 
CINVEN is a European private equity company, which has acquired several healthcare investments, since 
2004.   
 
Address: 
Cinven Limited 
Warwick Court 
Paternoster Square 
London EC4M 7AG 
Tel: +44 (0)20 7661 3333 
Fax: +44 (0)20 7661 3888 
www.cinven.com 
 
EWC:   NO but elegible? 
 
Total employees: 10,300 (including physicians under contract) 
 
Regional breakdown 
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Country Subsidiary Workers 
UK BUPA hospitals  
Partnerships in Care 
5,800 (including 3,300 clinicians) 
2,500 employees 
Spain USP Hospitales 2,000 physicians under contract 
  10,300 
 
Major European healthcare subsidiaries 
 
Country Subsidiaries 
UK BUPA hospitals  
 
UK Partnerships in Care 
Spain USP Hospitales 
 
 
Cinven, as a European private equity investor, has over a decade of experience of investing in healthcare 
companies.  In 2005, it bought Partnerships in Care from the General Health Group.  Partnerships in Care 
provide mental health services, specialist units for people with learning disabilities, brain injury rehabilitation 
units, community placements for supported living and an employee assistance programme.  Cinven had also 
invested in the General Health Group, which it sold in 2000. 
 
In 2007, it has made two significant healthcare investments.  It bought 25 hospitals from BUPA  and also 
bought a Spanish private hospital group, USP Hospitales Group, from Mercapital, a Spanish private equity 
group.  USP Hospitales Group is the leading independent operator in the Spanish private healthcare market 
and second largest provider to the private healthcare insurance market.  Cinven is aiming to expand the 
company through more acquisitions in Spain and in international markets.  USP has recently acquired a 25% 
stake in HPP, the fourth largest hospital group in Portugal.  Caixa Geral owned the remaining 75% of HPP.41 
 
These two recent acquisitions, suggest that Cinven has identified the European healthcare sector as an 
important source of investment.  Spain is considered to have a fast growing healthcare sector. Cinven has 
also built up some expertise in healthcare management over the past decade.  
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4.7 Company Name COMPASS 
 
Owner 
Compass Group PLC 
Compass House 
Guildford Street  
Chertsey, Surrey KT1 9BQ 
Tel +44 1932 573 000 
Fax +44 1932 569 956  
www.compass-group.com 
 
EWC: YES 
 
Total employees: 375,000 
 
Regional breakdown 
 
Region Sales % 
                         UK £3,060m 
 
23% 
Continental 
Europe  
£2,482m 22% 
North America £3,562m 32% 
Rest of world £1,918m 17% 
Total £11,286  
 
4.7.1 Major European subsidiaries   
 
Company Ownership Country 
Compass Contract Services (UK) 
Ltd 
Letheby & Christopher Ltd 
Scolarest Ltd 
Selecta UK Ltd 
Compass Purchasing Ltd 
100% 
 
100% 
 
100% 
100% 
UK 
Compass Group France SA 
Selecta SA 
100% 
100% 
France 
Eurest Deutschland GmbH  100% Germany 
Eurest Colectividades SA  100% Spain 
Compass Group Nederland BV 100% Netherlands 
Selecta AG  
Restorama AG 
Sevita AG 
100% 
100% 
100% 
Switzerland 
Onama SpA  95% Italy 
 
4.7.2 Company activities and strategy 
 
Compass is the world‟s largest contract catering company.  It has begun to diversity into facilities 
management.  In 2004/5, it reported a 50% drop in profits, which was partly the result of poor publicity in the 
UK for school meals, provided by Scolarest, following a series of television programmes by Jamie Oliver, 
who criticised the unhealthy content of school meals.  There was a drop of 30% in profits in the UK but in the 
United States, operating profits rose by 12%. 
42
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Compass is facing a deficit in its pension scheme.  Currently its assets are 67% of its liabilities. It has put 
£100 million into the pension deficit but the deficit rose from £426 to £530 over the past year. 
 
4.8 Company name EUROMEDIC INTERNATIONAL 
 
Owner:  EUROMEDIC INTERNATIONAL N.V.  
Central European Headquarters 
Gerbeaud House  
1, Dorottya St.  
1051 Budapest  
Hungary 
TEL.: +36 1 267 5314 
FAX: +36 1 267 5312 
E-mail: joseph.priel@euromedic-group.com 
www.euromedic-group.com 
 
EWC:  NO but elegible? 
 
Total employees 1,000? (2004) 
 
4.8.1 Major European subsidiaries  
 
Company Owner-
ship 
Country Contact Website 
Euromedic 
Diagnostics BV 
100% Hungary EUROMEDIC INTERNATIONAL N.V. - 
Central European Headquarters 
Gerbeaud House, 1. Dorottya St., 1051 
Budapest, Hungary 
TEL.: +36 1 267 5314 FAX: +36 1 267 
5312 E-mail: joseph.priel@euromedic-
group.com 
 
www.euromedic-
group.com 
International 
Dialysis Centre 
BV 
100%    
Euromedic 
International NV 
 Netherlands Holding company registered in The 
Netherlands 
 
Euromedic 
Bosnia Herz 
100% Bosnia 
Herzogovina 
EUROMEDIC Bosnia & Herzegovina 
Address: Bana Milosavljevica 8, Street, 
78000 Banja Luka 
Republic of Srpska 
Bosnia and Herzegovina 
Contact person: 
Mr. Marijan Bilic 
IDC General Director 
email: mbilic@inecco.net 
Mobile Phone:00-387-65-513-104 or 00-
387-65-633-778 
Telephone: 00-387-51-22-33-40 
Fax: 00-387-51-22-33-50 
 
www.euromedic-
group.com 
Euromedic 
Croatia 
 
 
 
  Hektorovicava 2/II, 10 000 Zagrebm 
Croatia 
Contact: Dr. Ivan Svajger, President 
Euromedic Croatia  
Tel: + 385 1 63 90 650 
Fax: + 385 1 63 90 660 
E-mail: ivan.svaiger@euromedic.hr 
 
 
Euromedic 
Czech Republic 
 
100%  EUROMEDIC Czech Republic sro 
Na Polkopi 
110 00 Praha 1, Czechrepublic 
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Contact person: Mr. David Karasek, 
Managing Director 
Tel: + 42 25753948 
Fax: +42  257539962 
E-mail: karasek@europmedic.biz 
Euromedic 
Greece 
 
 
100%  EUROMEDIC Greece 
76 Kifissias Av. & Pamonos Street 
15125 Marousi, Athens, Greece 
Contact: Mr. Dimitri Moulavasilis, 
President Euromedic Greece 
Tel:+ 30 210 614 8780 
Fax:+ 30 210 614 8782 
E-mail: 
dimitris.moulavasilis@euromedic.gr 
 
Euromedic  
Hungary 
100% Hungary EUROMEDIC DIAGNOSTICS Kft 
Gerbeaud House, 1. Dorottya St., 1051 
Budapest, Hungary 
Contact person: Dr. Zoltan Katona 
Tel: +361 327 4345 
Fax: +361 318 8687 
Email: katona.zoltan@euromedic-
group.com 
 
www.euromedic-
group.com 
Euromedic 
Ireland 
 
 
100%  Contact: Mr. Sean Eustace, Country 
Representative 
Tel: +352 14 582 546 
Mobile: +354 86 254 2420 
E-mail: eus@dubi.ie   
 
Euromedic 
International Srl 
 
 
 
 
100%  Via Privata Maria Teresa 4, 20123 
Milano, Italy 
Contact: Mr. Guiseppe Giannasio, 
President Euromedic International Srl 
Tel: 39 02 883936.1 
E-mail: info@euremedic.it 
 
 
Euromedic 
Portugal 
 
100% Portugal Av. D.Joao II, n.1.17.01 Edificio Toorreo 
Sen, 8 B Parque das Naccoes, 1998-
023 Lisboa. Portugal 
Contact: Mr. Antonio Marquez, 
Presidente Euromedic Portugal 
Tel: +351 91 936 93 38  
E-mail: antonio.marquez@euremedic.pt 
 
 
Euromedic 
Poland 
100% Poland EUROMEDIC International Polska Sp. z 
o.o. 
ul. Krucza 16/22, 00-526 Warszawa 
tel. (+48 22) 627 28 98, fax (+48 22) 
627 28 99 
e-mail: euromedic@euromedic.pl 
Contact person: Dr. Maciej Kowalski, 
President Euromedic Poland 
 
www.euromedic-
group.pl 
 
Euromedic Czech 
Republic 
100% Czech 
Republic 
EUROMEDIC Czech Republik, s.r.o., 
Malostranské nám. 5 
110 00 Prague 1 
tel. (+42) 257535948, fax.(+42) 
257535952 
e-mail: D.Karasek@seznam.cz 
Contact person: Mr. David Karasek, 
Managing Director 
 
www.euromedic-
group.com 
Euromedic Croatia 100% Croatia EUROMEDIC International d.o.o. 
Croatia, Kneza Borne 2, (1st Floor, 
Business Gallery, Sheraton Zagreb 
Hotel), 100000 Zagreb, CROATIA 
Tel.: +385 (0)1 46-46-777; or 778 
www.euromedic-
group.com 
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Fax: +385 (0)1 46-46-780 
e-mail: euromedic@inet.hr or: 
bg.euromedic@mail.inet.hr 
web-site: www.euromedic-group.com 
Contact person: 
Branko Gracanin, General Manager 
Euromedic 
Romania 
100% Romania EUROMEDIC Romania SRL 
35, Ermil Pangratti St., 5th level, Suite 
5, Sect. 1, Bucharest - Romania 
Tel/Fax; +40 1 230 23 13, + 40 1 231 26 
45, + 40 1 231 26 49 
E-mail:office@euromedic.ro 
Contact person: Mr. Zahal Levy, 
President Euromedic Romania 
 
www.euromedic-
group.com 
Euromedic 
Russia 
 
100% Russia 40 Building 4, Bolshaia Ordynka Street, 
Moscow, Russia, 119017 
Contact: Dr. Victor Molostov, Head of 
Representative Office 
E-mail: victor.molostov@euremedic.ru 
 
 
Euromedic 
Turkey 
 
100% Turkey IDC ULUSLARARASI DIYALIZ 
MERKEZLERI STI 
CUMHURIYET CAD NO.26 
Pegasus EV1 HARBIY, Istanbul 
Contct: Emir Ozler, President IDC 
Turkey 
Tel: + 90 212 241 5800 
Fax: +90 212 241 5820 
E-mail: emir@idcturkey.net 
 
 
 
 
4.8.2 Company activities and strategy 
Euromedic Diagnostics BV and International Dialysis Centre BV are both 100% owned Dutch subsidiaries of 
Euromedic International NV, a holding company of the group. 
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For more than a decade, Euromedic has been building and operating imaging diagnostic centres and dialysis 
centres in Eastern and Central Europe.  They work in public-private partnership arrangements, where 
Euromedic invests in the centres and the public healthcare system pays for the service.  
 
The history of Euromedic International provides an insight into the way in which healthcare companies are 
beginning to operate within a European market.   In 1991, two Hungarian entrepreneurs set up a company 
called International medical Centres in Budapest, which was owned by an Israeli company, Elbit.  In 1995, 
the Euromedic group of companies was set up with the Red Sea Group, also an Israeli company.  In 1998, 
these International Medical Centres merged with the Euromedic group.  In 1999, GE Capital and Dresdner 
Kleinwert Benson back the founders of Euromedic in a buyout from Elbit.  Euromedic International is formed.  
 
The following year, 2000, further capital was raised, underwritten by the Washington DC based company 
Global Environment Fund.  Euromedic International expanded into Poland, Bosnia – Herzogovina and 
Romania, opening up dialysis clinics. In November 2002, GE Capital and Dresdner Kleinwert Benson bought 
the Red Sea Group.  In 2005, Warburg Pincus and GE Healthcare and management bought out the three 
financial investors.  With support from the Dutch ING bank, they finance the company‟s growth plan, moving 
from Central and Eastern Europe to become a European- wide healthcare provider.  In 2006, Euromedic 
International expanded its activities and moved into Russia, Czech Republic, Greece and Turkey.  In 2007, it 
achieved a pan-European position by expanding into Italy, Portugal and Ireland.
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4.9 Company Name FRESENIUS 
 
Owner: Fresenius 
Head Office 
Fresenius AG 
Else-Kröner-Straße 1 
61352 Bad Homburg v.d.H. 
Germany 
Postal Address: 
Fresenius AG 
D-61346 Bad Homburg v.d.H. 
Tel: +49 6172 608 0 
www.fresenius.de 
 
EWC: YES 
 
Total employees: 107, 438  
 
Regional breakdown 
 
Region Number of  employees % employees 
Europe 52,644 49% 
North America 39,752 37% 
Latin America and 
other regions 
9,666 9% 
Asia-Pacific 5,370 5% 
Total 107,438  
 
4.9.1 Major European subsidiaries 
 
Company Owner- 
Ship 
Country Contact Website 
Fresenius 
Medical Care 
AG & CO KGaA 
Hof an der 
Saale  
 
Fresenius Kabi 
Deutschland 
GmbH 
Bad Homburg 
v.d.H. 
 
Fresenius 
Hemocare  
Deutschland 
GmbH 
Bad Homburg 
v.d.H. 
 
HELIOS Group, 
Berlin 
 
 
36.77% 
 
 
 
 
 
 
100% 
 
 
 
 
100% 
 
 
 
 
 
98% 
Germany Fresenius Kabi 
Deutschland GmbH 
Else-Kröner-Strasse 1 
61352 Bad Homburg 
Tel: +49 (0)6172 686 0 
Fax +49 (0)6172 686 
2628 E-mail: 
communication@freseni
us.kabi.com 
www.fresenius-kabi.de 
 
Fresenius Kabi, 
Italy S.p.A, 
Verona 
 
Fresenius 
100% 
 
100% 
Italy Fresenius Kabi Italia 
S.P.A. 
Via Camagre, 41 
37063 Isola della Scala 
www.fresenius-kabi.de 
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HemoCare Italia 
S.r.I. 
Medolla/Modena 
– Verona 
Tel:+39 045 6649 311 
Fax: 39 045 6649 404 
 
 VAMED Group, 
Vienna, Austria 
 
Fresenius Kabi 
Group GmbH 
Graz 
77% 
 
 
 
 
100% 
Austria Sterngasse 5, A-1230 
Vienna Tel:43/1/60 
127/0 Fax: 43/1/60 127/   
190 E-mail: 
office@vamed.co.at 
 
www.vamed.com 
 
Fresenius 
Hemocare  
Netherlands  
BV, Emmen, 
 
Fresenius Kabi 
Nederland B.V. 
's-
Hertogenbosch 
 
100% 
 
 
 
 
100% 
Netherlands Fresenius Hemocare 
B.V. 
Runde ZZ 41 
7881 HM Emmer-
Compascuum Tel : +31 
591 355 700 Fax +31 
591 355 555 E-mail@ 
customer_services@np
bi.nl 
www.npbi.nl 
 
Fresenius Kabi 
AB, Stockholm, 
Sweden 
100% Sweden Fresenius Kabi AB 
Rapsgatan 7, 
SE-751 74 Uppsala 
Tel:+46 18 64 4000 
Fax: +46 18 64 490 E-
mail: infor-
sweden@fresenius.kabi
.com 
www.fresenius-
kabi.com 
 
 
4.9.2 Company activities and strategy 
Fresenius is a “global health care company with products and services for dialysis, the hospital and the 
medical care of patients at home”.
45
   As a vertically integrated renal care company, Fresenius produces 
products and equipment for renal dialysis and runs dialysis clinics.  Increasingly the company is becoming 
more involved in the production of infusion therapies for patients at home as well as for a wider range of 
conditions than renal care, e.g. cancer care.   
 
The Fresenius Chairman pointed out in 2001 that there was the potential for Fresenius ProServe, the 
international management division, to expand because “health systems, not only in Germany but all over the 
world, are in a state of change which is marked by increasing privatisation of hospitals and the demand for 
qualified, economically-efficient care of patients”.
46
 Krick predicted that in Germany the current 7% of 
hospitals operated privately will increase and there will also be an increase in integrated hospital services 
where primary and secondary care are brought together. 
 
Developments since 2004, show that Fresenius has continued to expand its healthcare management 
business.  In 2005, Fresenius (ProServe, the healthcare management division) bought the HELIOS group, a 
German private hospital group, which has 55 hospitals and 26,000 employees.  The Wittgensteiner Klinken 
Group, which Fresenius bought in 2001, has been integrated into the HELIOS group.  In 2006, Fresenius 
bought the HUMAINE clinic group, with 6 hospitals and 2,900 employees.   
 
There are signs that the integration of HELIOS has not been so smooth.  The Herbolzhein hospital, Freiburg, 
has been returned to the local government, after being privatised and bought by the HELIOS group.  Ver-di  
considered that HELIOS were not interested in providing services for the local population.  Since the 
introduction of a pricing system, using diagnostic related groups (DRG), which involves payment for a 
condition rather than for specific treatments,smaller hospitals have been unable to compete successfully with 
larger hospitals.  Ver-di also accused HELIOS of “chaotic management” .
47
  
 
HELIOS made an agreement with Marburger Bund in December 2006.
48
  The Fresenius 2006 Annual Report 
also reported that there has been a group-wide wage tariff agreement with ver.di for 14,000 employees at 24 
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clinics, starting from 1 January 2007.  It has now established a European Company (SE) with workers 
participation on the board of the company. 
 
Fresenius, through VAMED, its international hospital projects division, has become involved in public-private 
partnerships in Austria and Bosnia Herzogovina in Europe.  In Austria, the projects involve clinics and a 
radiology centre.  In Bosnia, VAMED is modernising the University Hospital at Tuzla and building a new 
medical centre at Banja Luka.  VAMED is also contracted to deliver technical management for the Vienna 
General Hospital and manages the non-medical services contact for the Charite University Hospital, Berlin.  
It is also contracted to deliver technical management at Eppendorf University Hospital, Hamburg. 
 
Fresenius Medical Care, the dialysis clinics division, bought the Renal Care Group, a company providing 
kidney dialysis, in the United States in 2006, thus expanding its presence in North America. 
49
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4.10 Company Name GAMBRO Healthcare 
 
Owner  
In 2007, Gambro Healthcare was bought by Bridgepoint, a private equity company 
 
Gambro AB 
Head Office 
mailing address: P.O Box 7373 
SE-103 91   
STOCKHOLM 
visiting address: Jakobsgatan 6 
103 91  STOCKHOLM 
Tel: + 46 - 8 613 65 00 
Fax: + 46 - 8 611 28 30 
www.gambro.com 
 
EWC: YES? 
 
Total employees:  ?? 
 
4.10.1 Company activities and strategy 
 
Gambro, together with Fresenius and Baxter, is one of three global renal healthcare companies.  In the last 
decade it has expanded from manufacturing products for renal dialysis to running dialysis clinics.  Gambro 
makes dialysis products, operates dialysis clinics and supplies blood bank technology worldwide.   
 
In 2005, Gambro sold its US clinics to DaVita and established a strategic alliance with DaVita and Baxter, 
another global renal healthcare company.  In 2006, Gambro bought 11 clinics in Lithuania, as part of its 
expansion into central and eastern Europe. 
 
In June 2006, Indap AB, indirectly jointly-owned by EQT and Investor AB, bought Gambro. In November 
2006, the new owners decided to develop Gambro into three free-standing companies: Gambro (former 
Gambro Renal Products), Gambro BCT and Gambro Healthcare.
50
  In 2007, Gambro Healthcare was sold to 
Bridgepoint, a private equity group.  Gambro Healthcare has 155 clinics in 15 countries. 
51
  In Europe, it has 
clinics in Estonia, France, Hungary, Italy, Lithuania, Poland, Portugal, Spain, Sweden, and the UK.
52
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4.11 Company Name RENTOKIL INITIAL 
 
Owner   
Rentokil Initial plc 
Head Office 
Felcourt 
East Grinstead 
West Sussex 
RH19 2 JY 
Tel: +44 1342 833 022  
Fax: +44 1342 833029 
www.rentokil-initial.com 
 
EWC: YES 
 
Total employees: 92,447 
 
Regional sales 
 
Region Sales £m 
United Kingdom 1,153.4 
Continental Europe 771.7 
North America 315.1 
Asia Pacific and Africa 131.9 
Total £2,124m (2006) 
 
Major European subsidiaries 
 
Company Owner-
ship 
Country Website 
Dudley Industria Ltd 
Enviro-Fresh Ltd 
Initial Building Services Ltd 
City Link 
Initial Electronic Security 
Systems Ltd 
Initial Facilities Management Ltd 
Initial Hospital Services Ltd 
Rentokil Initial Services Ltd 
Rentokil Initial Uk ltd 
Rentokil Initial Facility Services 
(UK)Ltd 
Rentokil Insurance Ltd 
Target Express Parcels Ltd 
100% 
100% 
100% 
100% 
 
100% 
 
100% 
100% 
100% 
100% 
 
100% 
100% 
100% 
UK www.rentikil-initial.com 
 
Retail Cleaning Services Ltd  51% UK www.rentikil-initial.com 
Initial Catering Services Ltd 75% UK www.rentikil-initial.com 
Rentokil Initial GmbH 
Textilservice Pointner GmbH 
100% 
100% 
Austria www.rentikil-initial.com 
 
Initial Textiles NV 
Rentokil Initial NV 
100% 
100% 
Belgium www.rentikil-initial.com 
 
Initial Ecotex sro 100% Czech 
Republic 
www.rentikil-initial.com 
 
Rentokil Initial A/S 100% Denmark www.rentikil-initial.com 
Rentokil Initial Ltd 100% Ireland www.rentikil-initial.com 
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Oy Rentokil Initial AB 100% Finland www.rentikil-initial.com 
Initial BTB SA 
Initial Delta Securite SA 
Rentokil Initial SA 
Rentikil Plantes Tropicales SA 
 
 
100% 
100% 
100% 
100% 
France www.rentikil-initial.com 
 
Initial Textile Servies GmbH & 
Co KG 
Rentokil Initial GmbH 
100% 
100% 
100% 
Germany www.rentikil-initial.com 
 
Rentokil Initial Hellas EPE 100% Greece www.rentikil-initial.com 
Initial Textile Services Kft 100% Hungary www.rentikil-initial.com 
 
Rentokil Initial Ltd 100% Ireland www.rentikil-initial.com 
 
Rentokil Initial Italia SpA 100% Italy  www.rentikil-initial.com 
 
Initial Textile Luxembourg Sarl 
Rentokil Initial Sarl 
 
100% 
 
100% 
Luxembourg www.rentikil-initial.com 
 
Initial Dienstverlening Nederland 
BV 
Initial Hokatex BV 
Initial Varel security BV 
Rentokil Initial BV 
Rentokil Tropical Plants BV 
 
100% 
100% 
100% 
100% 
 
100% 
Netherlands www.rentikil-initial.com 
 
Rentolkil Initial Norge AS 
 
100% Norway  www.rentikil-initial.com 
 
Rentokil Initial Portugal-Servicos 
de Proteccao Ambiental Lda 
 
100% Portugal www.rentikil-initial.com 
 
Initial Textile Services Sro 100% Slovak 
Republic 
www.rentikil-initial.com 
 
Initial Gaviota SA 
Limpiezas Initial SA 
Rentokil Initial Espana SA 
100%10
0% 
 
100% 
Spain www.rentikil-initial.com 
 
Rentokil Initial AB 100% Sweden www.rentikil-initial.com 
 
Rentokil Initial AG 100% Switzerland www.rentikil-initial.com 
 
 
Source: Rentolkil Initial Annual Report  2006:p116 
 
4.11.1 Company activities and strategy 
Rentokil is one of the largest business services companies in the world, providing a range of support 
services.  It operates in four major sectors: hygiene, security, facilities management and parcels delivery.  It 
aims to continue to develop its business services in the major developed economies of the world, with a 
range of high growth and quality driven sectors, which generate cash and are in less cyclical markets using 
the strength of the Initial and Rentokil brands.  The company does not deliver healthcare services but 
delivers cleaning and support services to hospitals.  In 2006, it purchased two parcels delivery businesses: 9 
City Link franchises and Target Express. 
 
In 2005, Rentokil announced that it was consulting on closing its final salary pension scheme.  Like 
Compass, Rentokil has a deficit in its pension fund, which was estimated at £325 on 30 November 2005.  Its 
assets represent 68% of its liabilities.  Brendan Barber, TUC pointed out that “Rentokil enjoyed a pension 
holiday where the company did not make any contributions, from 1999 to 2004 at a time when the company 
was producing 20% profit growth and paying large dividends to shareholders”. In 2004 the company 
contributed £6.8m to plug a deficit of £187m. The deficit rose to £263m by December 2004 and then 
£286.5m by July 2005. 
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4.12 Company Name ISS 
 
Owner: PurusCo A/S, a consortium of EQT (a Swedish private equity company) and Goldmann Sachs 
Capital Partners 
 
ISS A/S 
Bredgade 30 
DK-1260 Copenhagen K 
Denmark 
Tel:  +45 38 17 00 00 
Fax: +45 38 17 00 11 
www.issworld.com 
 
EWC: YES 
 
Total employees:  391,400 (2006) 
 
 
Country Number of employees 
United Kingdom 39,170 
France 41,109 
The Netherlands 21,534 
Central Europe 19,392 
Germany 12,956 
Switzerland  8,821 
Austria 8,530 
Denmark (incl Iceland and Greenland) 13,844 
Sweden 11,117 
Belgium and Luxembourg 10,404 
Norway 17,907 
Spain 24,470 
Finland 12,061 
Israel 8,130 
Portugal 4,625 
Ireland 2,948 
Italy 567 
Asia (China, Singapore, Japan, Thailand, 
Indonesia, Brunei, Sri Lanka, Australia)  
72,776 
 
Latin America (Brazil, Argentina) 32,679 
Corporate headquarters 93 
Total 391,400 
 
 
4.12.1 Major European subsidiaries  
 
Company Owne
rship 
Country Contact Website 
ISS Facility 
Services A/S 
100% Denmark ISS Denmark A/S, Montmestervej 31,DK-2400 
Kobenhaven NV Tel:+45 38 17 1717 Arne 
Pedersen 
www.dk.issworld.com 
 
ISS Facility 
Services GmbH 
100% Austria ISS Facility Services GmbH Brunner Strasse 85, 
A01210 Vienna Tel: +43 1 291110 
Country Manager: Michael Maximilian  
www.at.issworld.com 
 
ISS Catering NV 
ISS Hygiene 
Services NV 
100% 
100% 
Belgium ISS NV Srteenstraat 20/1, B-1800 
Vilvorde/Koningslo 
Tel: +32 2 263 6611 Country Manager: Kris 
Cloots  
www.be.issworld.com 
 
ISS Kadroske 
usluge doo 
100% 
 
Croatia ISS Usluzne Djelatnosti doo, Trnjanska 72, CR-
10000 Zagreb Tel: +385 1 61 55 868 
www.hr.issworld.com 
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ISS Usluzne 
djelatnosti doo 
100% Country Manager: Davor Turcic 
ISS Facility 
Services sro 
 
100% Czech 
Republic 
ISS Facility Services sro, Pod Visnovkou 
1662/21 CZ-140 00 Prague 4 Tel: +42- 2 34 034 
376 
Country manager : Ladslav Burian 
www.cz.issworld.com 
 
ISS Eesti Ou 51% Estonia ISS Haldus Ou, Vilde tee 129, 12613 Tallinn Tel: 
+372 613 9107 
Country manager: Raul Parusk 
www.iss.ee 
 
ISS Hygiene 
Services SASU 
ISS Multiservices 
SAS 
100% 
 
100% 
France ISS ABilis France, 66-67. rue Ordener F-75018 
Paris, France  
Tel:+33 1 44 9248 48 
Hubert Boisson 
www.fr.issworld.com 
 
ISS Facility 
Services GmbH 
100% Germany ISS Holding GmbH, Keriastrasse 24 D-47269 
Duisburg Tel:+49 203 9982 0 
Rob Alsema 
www.de.issworld.com 
 
ISS Facility 
Services SA 
100% Greece ISS Servisystem SA, Demirdessious Str. 213, 
GR-142  33 Nea Ionia Tel:+309 10 27056 00-9 
Michelis Roussos 
www.gr.issworld.com 
 
ISS Servisystem 
Kft 
100% Hungary ISS Servisysten Kft, Gubacsi ut 6, H-1097 Tel: 
+36 1 216 3948 
Country manager: Gyorgi Gyorti 
www.hu.issworld.com 
 
ISS Ireland Ltd 100% Ireland ISS Ireland Ltd 11-13 Malpas Street, Dublin 8 
Tel:+353 1 453 7711 
www.ie.issworld.com 
 
ISS Facility 
Services Srl 
ISS Hygiene 
Services SRL 
100% 
 
100% 
Italy  ISS Facility Services Srl, Via Racito 5, I-200094 
Corsico Milano Tel: +39 -2 45 11 97 74 Country 
manager: Claudio Boni 
www.it.issworld.com 
 
ISS Palvelut Oy 100% Finland ISS Suomi Oy, Laulukuja 6, FIN-00421 Helsinki 
Tel:+358 205 155 
Matti Kyytsonen 
www.fi.issworld.com 
ISS Hospital 
Services BV 
100% Nether- 
lands 
ISS Netherlands, Atoomweg 484-6, NL-3542 AB 
Utrecht Tel:+31 30 242 43 44 Gerard Brand 
www.nl.issworld.com 
 
ISS Facility 
Services AS 
100% Norway ISS Norway a.s.,Ulvenveien 83, Postboks 132 
Okern N-0509 Oslo Tel:+ 47 2288 5000 
Bjorn Nilsen 
www.no.issworld.com 
 
ISS Facility 
Services zoo 
100% Poland ISS Facility Services SP zoo, Ut Jordanowska 
2A PL-04-204 Warsawa Tel: +48 22 879 93 91 
Country Manager: Artur Sarnecki 
www.pl.issworld.com 
 
ISS Portugal II 100% Portugal ISS Facility Services Ltda, Eua Moinho, da 
Barrunchada 4 1
st
 dt, P-2790-109 Carnaxide Tel: 
+351 21 424 67 60 
Country manager: Luis Andrade 
www.pt.issworld.com 
 
ISS Facility 
Services SRL 
100% Romania ISS Facility Services srl, B-du1 Ferdinand 1 nr. 
13, 021381 Sector 2, Bucharest Tel: +40 21 252 
47 85 
Country Manager: Dan Jacota 
www.ro.issworld.com 
 
Facility Services 
RUS LLC 
100% Russia Facility Services Rus OOO Bld.9, 9 Malaya 
Semenovskaya str. 107023 Moxcow Tel: +7 495 
933 44 73 
Country manager: Yevgeny Ilin 
 
ISS Facility 
Services spol sro 
100% Slovakia ISS Facility Services spol sro, Pluhova 50/A, 831 
03 Bratislava Tel: +421 2 49 20 05 30  
Country manager: Honor Ilavsky 
www.sk.issworld.com 
 
ISS Servisystem 
doo 
100% Slovenia ISS Servisystem doo, Ptujska cesta 95, 2000 
Maribor Tel: +386 2 450 33 00 
Country manager: Rudi Zupan 
www.si.issworld.com 
 
ISS Facility 
Services AB 
100% Sweden ISS Sverige AB Arstaangsvegen 25, Box 42071, 
S-126 13 Stockholm Tel:46 8 681 60 00  
Thomas Kolbe 
www.se.issworld.com 
ISS Facility 
Services AG 
100% Swizer-
land 
ISS Holding AG, Riedstrasse 12, CH-8953 
Dietikon Tel: +41 43 322 3636 
Country manager: Andre Nauer 
www.ch.issworld.com 
 
ISS Facility 
Services Ltd 
ISS Mediclean 
100% 
 
100% 
UK ISS UK Ltd. Wells House, 65 Boundary Road, 
Woking, Surrey GU21 5BS Tel:+44 1483 754 
900 
www.uk.issworld.com 
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Ltd 
ISS Facility 
Services SA 
100% Spain ISS Facility Services SA, C/Fedanci 8-10, E-
08190 Sant Cugat del Valles Tel:+34 93 5 903 
060 
Country manager: Joaquim Borras Ferre 
www.es.issworld.com 
 
 
4.12.2 Company activities and strategy 
International Service Systems ISS, a Danish company, runs a global facilities management business.   It has 
developed an increasingly integrated set of services, with a growing consolidation of suppliers, in the five 
years.  ISS is one of the 10 largest employers in Europe.  Cleaning services represent 57% of sales in 2006.  
Some are delivered in the hospital sector.  ISS has also been involved in several Public Finance Initiatives in 
the UK. 
 
In April 2005, PurusCo A/S, a consortium of EQT (a Swedish private equity company) and Goldmann Sachs 
Capital Partners bought ISS.  The company was then de-listed from the Copenhagen Stock Exchange, in 
June 2005. It is now a private company.  ISS shareholders are currently assessing the feasibility of an Initial 
Public Offering (IPO),within the next 12 months, which would refloat the company in the Danish stock 
exchange.
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ISS sold its health care operations in 2005.  The company also sold its 49% interest in CarePartner, a care 
services company,  to a joint venture to Aleris Holding AB, which was owned by ISS, EQT III Ltd and Aleris‟s 
management.  ISS then sold its interest in this joint venture to EQT III.
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In the UK, in 2005, ISS sold its PFI stake in Catalyst Healthcare (Worcester) Ltd, which was operating 
Worcester Hospital.  It gained DKK 33 million  
56
 
 
In 2006, ISS sold a company that had been active in a public-private partnership in Slovenia.
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4.13 Company name MEDICOVER 
 
Owner: Celox SA 
 
Address:   
Medicover Holding SA  
20 rue Phillippe II,  
L-234- Luxembourg 
Tel: +352 26203110  
Fax: +352 2620 3234 
 
Medicover c/o Beiro Medical SA,  
Waterloo Office Park  
Building O, Dreve Richelle 161  
B-1410 Waterloo, Belgium  
Tel: +32 3 357 55 77  
Fax: : +32 3 357 55 05  
E-mail: info@medicover.com 
 
EWC: NO but eligible? 
 
Total employees: 1,587 (end 2005) 
 
Regional breakdown 
 
Company name Number of employees (2005) Revenues (€m) 
Medicover Poland 800 33.4 
Medicover Romania ? 6.5 
Medicover Hungary ? 3.1 
Medicover Estonia ? 1.8 
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Medicover Czech Republic ? 2.1 
Medicover Laboratories ? 14.0 
Total 1,587 60.0 
 
4.13.1 Major European subsidiaries 
 
Company Owner-
ship 
Country Contact Website Employees 
(2001) 
Medicover 
(Czech 
Republic) 
100% Czech 
Republic 
Medicover Czech 
Lomnického 1705/5 
Prague 4 
140 00, Czech Republic 
Phone: +420 234 630 111 
Fax: +420 224 255 730 
E-mail: info@medicover.cz  
 
www.medicover.cz 70 
Medicover 
Aesti AS  
100% Estonia Medicover Estonia  
Pärnu mnt, 102c 
11312  Tallinn 
Estonia 
Phone: +372 605 1550 
fax: +372 605 1515 
E-mail: info@medicover.ee 
 
 
www.medicover.es 
 
68 
Medicover 
Klinika Rt. 
100% Hungary Medicover Hungary 
Montevideo u. 5 
1037 Hungary 
Phone: +36 1 465 3150 
Fax: +36 1 465 3160 
E-mail: info@medicover.hu 
 
 
www.medicover.hu 
 
96 
Medicover  
Romania 
 
 
 
100% Romania Medicover Romania 
16-20 Grigore Alexandrescu St., 2nd 
Floor, Sector 1 Bucharest 
Romania 
Phone: +4021 310 16 99 
Fax: +4021 310 17 43 
E-mail: romania@medicover.com 
www.medicover.ro 
 
 
Medicover 
Rombel SRL 
100% Romania Synevo  (Medicover Rombel srl ) 
Str. Ion Campineanu 11, Etaj 4, 
Sector 1, Bucuresti 
Tel.: (00 4021) 315 19 10/11 
Fax: (00 4021) 315 19 93 
E-mail: office@synevo.ro, 
laborator@synevo.ro 
 
www.synevo.ru 
 
 
330 
Medicover 
Sp.zo.o. 
100% Poland Medicover Poland 
ul. Bitwy Warszawskiej 1920 r 18 
02-366 Warsaw 
Poland 
Phone: +48 22 592 7000 
Fax:     +48 22 592 7099 
E-mail: info@medicover.pl 
 
www.medicover.pl 
 
678 
Synevo 
Polska SP 
Zoo 
100% Poland Synevo Medical (Poland) Sp.z o.o 
ul. Dzika 4 , 00-194 Warszawa 
Tel.: + 48 22 636 37 82 
Fax : +48 22 636 37 88 
E-mail: biuro@synevo.pl, 
laboratorium@synevo.pl 
www.synevo.pl 
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4.13.2 Company activities and strategy 
 
Medicover was established in 1995 by Oresa Ventures, a Swedish venture capital company.  The company 
offers both medical insurance and a health care delivery system, to its clients. Medicover employs most of its 
physicians directly and provides health care through its own facilities.  
 
Prepaid members 
Company name Prepaid members (2002) Prepaid members (2005) 
Medicover Poland 77,600 126,300 
Medicover Romania 14,000 34,800 
Medicover Hungary 1,700 8,000 
Medicover Estonia 2,400 6,800 
Medicover Czech 
Republic 
- 14,800 
Total 95,700 190,700 
 
Medicover provides health insurance for corporations and individuals,  and delivers health care services 
through health centres staffed by its own doctors and nurses, and on-site workplace facilities for large 
employers. 
 
In 2005, Medicover bought two laboratories in Poland (Wroclaw and Lodz) and a private hospital in Warsaw.  
It also bought 40% in Centrum Medyczne Damiana in Poland, a provider of clinical and hospital services.  
The company also rebranded its laboratory services, Medicover Rombel, and renamed them Synero in 
Poland and Romania.  In Poland, Synero has several outsourcing contracts from public hospitals.  Medicover 
also provides laboratories and logistics for clinical trials for sites in Poland, Czech Republic, Hungary, 
Slovakia, Romania, Lithuania, Latvia, Russia and the UK..
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In 2006, Medicover was bought by Celex SA, whose owner was also Chairman of Medicover, Jonas af 
Jochnick, who originally owned 35% of Medicover shares.  The company was delisted in 2006. 
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4.14 Company Name SODEXHO 
 
Owner:  
Sodexho Group 
Parc d'Activites du Pas-du-Lac 
3 avenue Newton 
78180 Montigny-le-Bretonneux 
France 
Tel : +33 01 30 85 75 00 
Fax : +33 01 30 43 09 58 
www.sodexho.com 
 
EWC: YES 
 
Employees: 324,446 
 
Regional employees and sales 
 
Region Employees % Sales % 
North America 120,157 37% €m 43% 
Continental Europe 87,220 27% €m 34% 
UK/ Ireland 47,515 14% €m 11% 
Africa, Asia and 
Pacific rim 
69,504 21% €m 12% 
     
Total 324,446    
4.14.1 Major European subsidiaries  
 
Company Ownership Country Contact Website 
Sodexho Ltd FFMS 
 
Sodexho 
Healthcare 
Services  FFMS 
 
King’s College 
Hospital (Holdings) 
Ltd FFMS 
 
Catalyst Healthcare 
(Romford) Holdings 
Ltd FFMS 
 
Catalyst Healthcare 
(Roehampton) 
Holding Ltd FFMS 
 
Catalyst Healthcare 
(Manchester) 
Holding Ltd FFMS 
 
Mercia Healthcare 
(Holdings) Ld 
 
South Manchester 
Healthcare 
100%  
 
100% 
 
 
 
25% 
 
 
 
25% 
 
 
 
 
 
25% 
 
 
 
 
25% 
 
 
 
 
25% 
United 
Kingdom 
 
 
 
 
 
 
Sodexho Ltd 
Kenley House 
Kenley Lane 
KENLEY 
Surrey 
CR8 5ED 
Tel:020 8763 1212 
Fax:020 8763 1044 
http://www.sodexho-
uk.com/ 
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Holdings LTD  
 
25% 
Sodexho Nederland 
BV 
100%  Netherlands Capelle aan den 
IJssel 
Rivium Boulevard 2 
2909 LK CAPELLE 
AAN DEN IJSSEL 
Tel.: (010) 288 4288 
Fax: (010) 288 4222 
info@sodexho-
nl.com 
 
http://www.sodexho-
nl.com/ 
 
Sodexho Oy 
 
100% Finland käyntiosoite 
Sentnerikuja 3, 2 krs. 
00440 Helsinki 
postiosoite 
PL 18 
00441 Helsinki 
  
Tel:09 5407 70 
E-mai l : 
etunimi.sukunimi@so
dexho.fi 
 
www.sodexho.fi 
 
Sogeres SA 100% 
Sodexho 
Alliance 
France 42/44 Rue de 
Bellevue 
92105 Boulogne 
Billancourt France 
Tel :  +33 1 46 99 33 
33 Fax :  +33 1 46 05 
55 59 
contact@sogeres.fr 
 
www.sogeres.fr 
 
Sodexho Italia  100%  Italy sede@sodexho-
it.com 
 
http://www.sodexho-
it.com/ 
 
Sodexho Belgique  100%  Belgium Services Catering et 
Gestion de Services 
11 rue des Trois 
Cantons 
L-8399 Windhof 
Grand Duché de 
Luxembourg 
Commercial : Marc 
Wolwertz 
Tél : +352 
26.106.281 
Fax : +352 26109 
209 
e-mail : 
marc.wolwertz@sod
exho.lu 
 
www.sodexho-be.com 
 
Sodexho Catering 
and Services 
GmbH 
100% 
Sodexho 
Alliance 
Germany info@sodexho.de 
 
www.sodexho.de.com 
 
Sodexho Suisse 100% Switzerland Place Saint Gervais 1 
BP 5349 1211 
Genève 11 
Tel: +41 (0) 22 716 
51 00 
Fax: +41 (0) 22 716 
51 05 
Contact email: 
olivier.mouminoux@s
odexho.ch 
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Sodexho Espana 100% Spain - SODEXHO SPAIN 
Recinto Industrial 
Colonia Güell 
Edificio Tint Vell 
Calle C, nº 24 
Santa Coloma de 
Cervelló  
Barcelona 08690 
Tel: +34 936 352 200  
Fax: +34 936 308 885 
Contact email: 
info@sodexho.e 
www.sodexho.es 
 
 
 
4.14.2 Company activities and strategy 
The Sodexho Group works in the following sectors: business and industry, defence, correctional services, 
healthcare, education, older people as well as in remote sites.  It also manages vouchers and card schemes.   
 
In the healthcare sector, Sodexho provides a range of services, often described as multi-service, to hospitals 
and to older people‟s care homes.  These services may include, catering, cleaning, housekeeping, building 
maintenance and management of paramedical staff.  Services delivered within the health care sector provide 
24% of total revenue.
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  In continental Europe and the UK/Ireland, services delivered in the healthcare sector 
represent 20% sales.  
 
Sodexho is continuing to develop partnerships with public and private sector organisations in order to deliver 
services.  In the UK it is involved in several PFI project both as an operator and as an investor. 
 
Sodexho has continued to expand its clients in the healthcare sector in 2005.  These include the Ebel Clinics 
(Germany), La Cote Hospital (Switzerland), Albert Schweitzer Hospital (Colmar, France), Sagessa 
Residences (Tarragona, Spain),  Queen Mary Hospital (UK) and Capio Spine Chain (UK).
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5 Non-EWC eligible companies 
5.1 Company name  ADESLAS 
 
Owners:  
Aguas de Barcelona  54.79%  
Mederic 45% 
 
Address: 
Compania de Seguros Adeslas SA 
Principe de Vergara, 110 
10 – 28002 Madrid  
Spain 
Tel: 91 566 50 00 
Fax: 91 563 43 20 
www.adeslas.es 
 
EWC: NO 
 
Number of employees: 2,915 (2,066 hospital employees and 849 insurance employees) 
 
5.1.1 Company activities and strategy 
Adeslas is a Spanish health care company operating both health insurance and health care services.   Its 
insurance division specialises in the production, management and distribution of health insurance policies. It 
has about 1.5 million members and about 25% of the Spanish health insurance market.   
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The healthcare management division directly manages 11 clinics and hospitals with over 1000 beds.  
Adeslas took over the management of the Ribera Public Hospital in Valencia in 1998.  This was an initial 
attempt by the regional government to privatise public hospitals.  There have been reductions in staff and in 
the quality of service since Adeslas started to manage the hospital. 
 
The Valencia Government was one of the first regional governments to use private management methods in 
the public health sector.  On 1 January 1999, Adeslas, a Spanish health insurance and health services 
company took over the management of Alzira Hospital, previously the publicly owned Hospital de la Ribera, 
Valencia.   Adeslas (51%) together with two banks - Bancaixa and the Caja de Ahorros del Mediterráneo 
(45%) - and two construction companies - Dragados  (construction and services) and Lubasa (2% each) – 
formed the Union Temporal de Empresas (UTE), which was given the concession to build and manage the 
public hospital for 10 years.  The group was paid a set amount per head of population each year, initially 
34,000 pesetas per head. 
61
 
    
 
In  2006, Adeslas bought three hospitals: La Policlinica San Jose, Vitoria and 90% of Clinica Santa Catalina 
Las Palmas de Gran Canaria, Santa Cruz de Tenerife.  Adeslas also „collaborates‟ with MUFACE, the civil 
service health insurance company and MUGEJU, the mutual company for judicial staff. 
 
Adeslas is owned by Aguas de Barcelona, the water and waste management company.  In July 2003, Aguas 
de Barcelona sold 25% of its holdings in Adeslas to Mederic, a French insurance company.   By 2007, 
Mederic had increased its holding to 45%.  
 
5.2 Company name GENERALE DE SANTE 
 
Owner:  
Generale de Sante 
96, avenue d‟Iéna 
75783 Paris Cedex 16 
Tel: +33 (0) 1 53 14 99 
www.generale-de-sante.com 
 
EWC:  NO eligible ? 
 
Total employees: 18,916 employees and 4,900 medical practitioners   
 
Regional revenues (€ million) 
 
Country 2005 2006 % (2006) 
France €1,351.0 €1,651.8m 94.8 
Italy €84.5 €89.7m 5.2 
Total €1,435.5 €1,741.5 100% 
 
5.2.1 Major European subsidiaries (addresses to be added) 
 
Company Ownership Country Contact Website 
Compagnie 
Generale de 
Sante 
100% France 96, avenue d’Iéna 
75783 Paris Cedex 16 Tel: +33 
(0) 1 53 14 99  
www.generale-de-sante.fr 
 
Gle de Santa 
Italia SPA 
 
100% Italy   
Casa Santa 
Rita 
98.51% Italy Via Manin 29 51016 
MONTECATINI – TERME 
Tel: 00 39 0572 91 16 88 Fax: 
00 39 0572 92 82 83 
www.generale-de-sante.fr 
 
Generale de 
Sante 
98.51% Italy Piazza Matteotti 33 53100 
SIENNE 
www.generale-de-sante.fr 
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Toscana (ex  
Rugani) 
Tel:00 39 0577 26 16 11 Fax: 
00 39 0577 27 13 43 
Centro 
Cardinal 
Farrari 
100% Italy Via IV Novembre, n°21 43012 
FONTANELLATO 
Tel: 00 39 (0)521 82 02 11 Fax: 
00 39 (0)521 82 02 52 
www.generale-de-sante.fr 
 
Centro 
Diagnostico 
San Nicolo 
(Como) 
100% Italy Via Recchi, 7 22100 COMO 
Tel:00 39 031 33 81 170 Fax: 
00 39 031 33 81 122 
www.generale-de-sante.fr 
Ospedale de 
Omegna 
49% Italy   
 
 
 
Casa Di Cura 
San Secondo 
De Asti 
100% Italy Via Pietro micca, 24 14100 Asti 
Tel: 00 39 0141 43 48 66 
Fax:  00 39 0141 43 48 12 
 
Poggio Del 
Sole 
98.51% Italy Via Fra Guittone n 2 52100 
Arrezo 0575 35 38 92   
Tel:  0575 27056   
E-mail: 
poggiodelsole@gsante.it  
 
Villa Maria 
Teresa 
98.51 Italy    
Il Pergolino 98.51 Italy   
Centro Analisi 
A. Fleming 
SPA 
100% Italy   
 
 
5.2.2 Company activities and strategy 
Generale de Sante is a leading private healthcare company in France with 10% of the market.  The 
company‟s aim is to be “a key player in the private hospital sector in France”. 
 
Generale de Sante provides mental health services, oncology and radiation therapy, sub-acute care (e.g., 
alcohol abuse and obesity treatments) and rehabilitation (cardiac rehabilitation, orthopaedic and neurological 
rehabilitation) services as well as diagnostics (medical imaging and analysis) and home healthcare for 
elderly or disabled people. 
 
Generale de Sante works in partnership with the public hospital sector.  This involves the creation of 
cooperative structures, Public Health Cooperation Associations, dividing their activities between a hospital 
and a clinic located on the same premises, notably in Gassin (Var), Dunkirk (Nord), and Avicenne (Ile-de-
France). 
 
In 2003, Generale de Sante main aims were to have 20% of the market share within 5 years, to pursue 
developments in Italy and to increase profitability.  At the end of 2003, the company had sold its Canadian 
residential care homes.  This also involved the removal from the scope of consolidation of two hospital 
investments in Venezuela and Chile.  
 
Until June 2003, Cinven has held 44% of the shares of Sante Luxembourg  (Vivendi Universal 20% and ABN 
AMRO and Capital France), which held 38% of General de Sante shares.  There was an agreement at the  
flotation in 2000, that Sante Luxembourg would hold shares for three years.  In June 2003, Sante 
Luxembourg shares were sold to Sante Holdings, an Italian holding company owned by Antonino Legresti.  
Sante Holdings is backed by Efibanca, an Italian regional bank.  Sante expects to sell 8% its share capital to 
Eficanca.  The balance of Sante Luxembourg‟s shares (6.5%) will be placed with French and UK investors 
with no one investor acquiring more than 1.75% shares. 
 
Sante Holdings is chaired by Antonino Ligresti, a cardiologist and healthcare entrepreneur who was 
acquitted in 1997 for a fire in a ”iperbarica”  (high compression)  chamber of a clinic in Milan which caused 
the deaths of 11 people.  However a recent Supreme Court ruling annulled his acquittal. (17.12.2003). 
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In January 2006, Generale de Sante bought ten clinics from the Hexagone Hospitalisation Group, which was 
the largest acquisition since the company was set up.  In September 2006, the company sold various 
property assets to Sofco, which is part of the Gecina group.  
 
In July 2007, Sante Developpement Europe SAS, which is owned by Antonio Ligresti, acquired 79.84% of 
the share capital and voting rights of Generale de Sante.  This was achieved through De Agostini SpA unit 
DEA Capital SpA buying Sante SA (Sante Luxembourg).  The ownership structure of Sante SA (Sante 
Luxembourg) is now: 
 Sante Holdings Srl (owned by Antonio Ligresti) 49% 
 DeA Capital Investment 43% 
 Mediobanca 9.99%  
Sante Luxembourg and Sante Developpement Europe SAS now control 80% of Generale de Sante shares.
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5.3 Company name JOSE DE MELLO SAUDE 
 
Owner Grupo Jose de Mello  
José de Mello - SGPS, SA 
Avenida 24 de Julho, 24 
1200-480 Lisboa 
Tel: 21 391 60 00 
Fax: 21 391 61 70 
E-mail: info@josedemello.pt 
www.josedemello.pt 
 
EWC:  No 
 
Total employees:   2,100 
 
5.3.1 Company activities and strategy 
Jose de Mello Saude is part of the De Mello group, a large Portuguese holding company.  The healthcare 
company has 976 beds distributed between three hospitals – Amadora Sintra, CUF Infante Santo and CUF 
Descobertas.  It has recently entered the Spanish market by buying 35% of Hospital Group Quiron, a 
Spanish private hospital group.
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José de Mello Residências e Serviços is the José de Mello Group holding company that manages Senior 
Care Residential Solutions.  The company owns Domus Vida and Domus Clube brands which provide 
independent and assisted living, with units in Junqueira, Parque das Nações and Parede.  It also owns 
DomusCare, which delivers home care services.   
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